CAROLYN POLCARI: Open Payments
NPI 1972050565 · ISSAQUAH, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$641 in 23 payments from 9 companies in 2025. Trend: 2023 $377 · 2024 $572 · 2025 $641
Food & beverage: $641
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $154 |
| GENZYME CORPORATION | 7 | $142 |
| Arcutis Biotherapeutics, Inc. | 2 | $138 |
| Incyte Corporation | 4 | $85 |
| Novartis Pharmaceuticals Corporation | 2 | $44 |
| Lilly USA, LLC | 1 | $24 |
| UCB, Inc. | 1 | $24 |
| Regeneron Healthcare Solutions, Inc. | 1 | $17 |
| Galderma Laboratories, L.P. | 1 | $13 |
Products named: DUPIXENT, Zoryve, Opzelura, BOTOX, TALTZ, Bimzelx, SKYRIZI, COSENTYX.
Industry payments across WA — which companies pay providers there.
